Since its establishment in 2005, the New York University Protein Mass Spectrometry Core Facility for neuroscience has provided cutting edge mass spectrometry-based protein analysis to molecular neuroscientists at the New York University School of Medicine. The purpose of this grant is to provide continued funding to enable neuroscientists at NYU to take advantage of sophisticated and involved protein mass spectrometry and proteomics that would otherwise not be available to them, and guarantee them access to the technology. The proposed Protein Mass Spectrometry Core Facility for Neuroscience would enable NINDS- and other NIH- funded neuroscientists at New York University to identify from one to thousands of proteins of interest, to characterize posttranslational modifications of these proteins such as phosphorylation, glycosylation, proteolysis and modification by lipids, to perform functional proteomics studies to identify the proteins involved in key signal transduction processes in neurons, to characterize protein-protein interactions by surface plasmon resonance and to perform automated RNAi experiments. Research areas that would greatly benefit from this core facility include nerve growth and regeneration, neuromuscular junction formation, cancer metastasis, axon guidance, axon domain assembly, lesion induced synaptic plasticity, potassium channel function, Alzheimer's and other amyloid diseases, brain development, aging, brain cancer, and neurotransmitter receptor trafficking.
The NYU Mass Spectrometry Core Facility for Neuroscience ensures that neuroscientists have access to cutting edge mass spectrometry technology to enable their basic research in such key areas as nerve growth and regeneration, neuromuscular disorders, cerebral hemorrhagic stroke, nervous system development, synaptic plasticity, affective disorders such as depression, Alzheimer's and other amyloid diseases, and aging.
|Deng, Jingjing; Zhang, Guoan; Neubert, Thomas A (2018) Metabolomic Analysis of Glioma Cells Using Nanoflow Liquid Chromatography-Tandem Mass Spectrometry. Methods Mol Biol 1741:125-134|
|Cabrera, Erwin; Mathews, Paul; Mezhericher, Emiliya et al. (2018) A? truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition. Biochim Biophys Acta Mol Basis Dis 1864:208-225|
|Erdjument-Bromage, Hediye; Huang, Fang-Ke; Neubert, Thomas A (2018) Sample Preparation for Relative Quantitation of Proteins Using Tandem Mass Tags (TMT) and Mass Spectrometry (MS). Methods Mol Biol 1741:135-149|
|Deng, Jingjing; Erdjument-Bromage, Hediye; Neubert, Thomas A (2018) Quantitative Comparison of Proteomes Using SILAC. Curr Protoc Protein Sci :e74|
|Choi, Meena; Eren-Dogu, Zeynep F; Colangelo, Christopher et al. (2017) ABRF Proteome Informatics Research Group (iPRG) 2015 Study: Detection of Differentially Abundant Proteins in Label-Free Quantitative LC-MS/MS Experiments. J Proteome Res 16:945-957|
|Gauthier, Sébastien A; Pérez-González, Rocío; Sharma, Ajay et al. (2017) Enhanced exosome secretion in Down syndrome brain - a protective mechanism to alleviate neuronal endosomal abnormalities. Acta Neuropathol Commun 5:65|
|Snuderl, Matija; Zhang, Guoan; Wu, Pamela et al. (2017) Endothelium-Independent Primitive Myxoid Vascularization Creates Invertebrate-Like Channels to Maintain Blood Supply in Optic Gliomas. Am J Pathol 187:1867-1878|
|Kang, Min-Ji; Vasudevan, Deepika; Kang, Kwonyoon et al. (2017) 4E-BP is a target of the GCN2-ATF4 pathway during Drosophila development and aging. J Cell Biol 216:115-129|
|Huang, Zhifeng; Tan, Yi; Gu, Junlian et al. (2017) Uncoupling the Mitogenic and Metabolic Functions of FGF1 by Tuning FGF1-FGF Receptor Dimer Stability. Cell Rep 20:1717-1728|
|Stathopoulou, Athanasia; Chhetri, Jyoti B; Ambrose, John C et al. (2017) A novel requirement for DROSHA in maintenance of mammalian CG methylation. Nucleic Acids Res 45:9810|
Showing the most recent 10 out of 78 publications